Author Contributions
Conceptualization, Y.N., J.H., and T.W.; formal analysis, Y.N., J.H., M.S., Y.Z., and Z.G.; investigation, Y.N., L.Z., X.Z., and C.W.; writing—review and editing, Y.N., H.A., and T.W.; supervision, T.W.; project administration, Y.N. and T.W.; funding acquisition, L.Z., C.W., X.Z., and T.W.
Figure 1.
Effects of intrauterine growth retardation on the concentrations of MDA (A) and H2O2 (B), and activities of AST (C) and ALT (D) in the serum of newborn piglets (0 d). Values expressed as mean ± standard deviation, n = 8/group. Data were analyzed using unpaired independent t-tests. * A significant difference was observed (p < 0.05). NBW, normal birth weight; IUGR, intrauterine growth retardation; MDA, malondialdehyde; H2O2, hydrogen peroxide; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Figure 1.
Effects of intrauterine growth retardation on the concentrations of MDA (A) and H2O2 (B), and activities of AST (C) and ALT (D) in the serum of newborn piglets (0 d). Values expressed as mean ± standard deviation, n = 8/group. Data were analyzed using unpaired independent t-tests. * A significant difference was observed (p < 0.05). NBW, normal birth weight; IUGR, intrauterine growth retardation; MDA, malondialdehyde; H2O2, hydrogen peroxide; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Figure 2.
Concentrations of MDA (A) and H2O2 (B) in the serum of normal-birth-weight piglets (N), normal-birth-weight piglets supplemented with curcumin (NC), intrauterine growth retardation piglets (I), intrauterine growth retardation piglets supplemented with curcumin (IC) (50 d). Values expressed as mean ± standard deviation, n = 8/group. Data were analyzed by using two-way analysis of variance. Significant differences marked with different letters when a significant interaction was observed (p < 0.05). B × D was the interaction between the corresponding parameters. MDA, malondialdehyde; H2O2, hydrogen peroxide.
Figure 2.
Concentrations of MDA (A) and H2O2 (B) in the serum of normal-birth-weight piglets (N), normal-birth-weight piglets supplemented with curcumin (NC), intrauterine growth retardation piglets (I), intrauterine growth retardation piglets supplemented with curcumin (IC) (50 d). Values expressed as mean ± standard deviation, n = 8/group. Data were analyzed by using two-way analysis of variance. Significant differences marked with different letters when a significant interaction was observed (p < 0.05). B × D was the interaction between the corresponding parameters. MDA, malondialdehyde; H2O2, hydrogen peroxide.
Figure 3.
Effects of intrauterine growth retardation on the concentrations of MDA (A) and PC (B), activities of TNOS (C) and iNOS (D) in the liver of newborn piglets (0 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed using unpaired independent t-tests. * a significant difference was observed (p < 0.05). NBW, normal birth weight; IUGR, intrauterine growth retardation; MDA, malondialdehyde; PC, protein carbonyl; TNOS, total nitric oxide synthase; iNOS, inducible nitric oxide synthase.
Figure 3.
Effects of intrauterine growth retardation on the concentrations of MDA (A) and PC (B), activities of TNOS (C) and iNOS (D) in the liver of newborn piglets (0 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed using unpaired independent t-tests. * a significant difference was observed (p < 0.05). NBW, normal birth weight; IUGR, intrauterine growth retardation; MDA, malondialdehyde; PC, protein carbonyl; TNOS, total nitric oxide synthase; iNOS, inducible nitric oxide synthase.
Figure 4.
Concentrations of MDA (A) and H2O2 (B), activities of TNOS (C) and iNOS (D) in the liver of normal-birth-weight piglets (N), normal birth weight piglets supplemented with curcumin (NC), intrauterine growth retardation piglets (I), intrauterine growth retardation piglets supplemented with curcumin (IC) (50 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed by using two-way analysis of variance. Significant differences are marked with different letters when a significant interaction was observed (p < 0.05). B × D was the interaction between the corresponding parameters. MDA, malondialdehyde; H2O2, hydrogen peroxide; TNOS, total nitric oxide synthase; iNOS, inducible nitric oxide synthase.
Figure 4.
Concentrations of MDA (A) and H2O2 (B), activities of TNOS (C) and iNOS (D) in the liver of normal-birth-weight piglets (N), normal birth weight piglets supplemented with curcumin (NC), intrauterine growth retardation piglets (I), intrauterine growth retardation piglets supplemented with curcumin (IC) (50 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed by using two-way analysis of variance. Significant differences are marked with different letters when a significant interaction was observed (p < 0.05). B × D was the interaction between the corresponding parameters. MDA, malondialdehyde; H2O2, hydrogen peroxide; TNOS, total nitric oxide synthase; iNOS, inducible nitric oxide synthase.
Figure 5.
Effects of intrauterine growth retardation on the expression of Nrf2 (A) and Hmox1 (B) in the liver of newborn piglets (0 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed using unpaired independent t-tests. * A significant difference was observed (p < 0.05). NBW, normal birth weight; IUGR, intrauterine growth retardation. Nrf2, nuclear factor, erythroid 2-like 2; Hmox1, heme oxygenase 1.
Figure 5.
Effects of intrauterine growth retardation on the expression of Nrf2 (A) and Hmox1 (B) in the liver of newborn piglets (0 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed using unpaired independent t-tests. * A significant difference was observed (p < 0.05). NBW, normal birth weight; IUGR, intrauterine growth retardation. Nrf2, nuclear factor, erythroid 2-like 2; Hmox1, heme oxygenase 1.
Figure 6.
Expressions of Nrf2 (A) and Hmox1 (B) in the liver of normal-birth-weight piglets (N), normal-birth-weight piglets supplemented with curcumin (NC), intrauterine growth retardation piglets (I), intrauterine growth retardation piglets supplemented with curcumin (IC) (50 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed by using two-way analysis of variance. Significant differences are marked with different letters when a significant interaction was observed (p < 0.05). B × D was the interaction between the corresponding parameters. Nrf2, nuclear factor, erythroid 2-like 2; Hmox1, heme oxygenase 1.
Figure 6.
Expressions of Nrf2 (A) and Hmox1 (B) in the liver of normal-birth-weight piglets (N), normal-birth-weight piglets supplemented with curcumin (NC), intrauterine growth retardation piglets (I), intrauterine growth retardation piglets supplemented with curcumin (IC) (50 d). Values are expressed as mean ± standard deviation, n = 8/group. Data were analyzed by using two-way analysis of variance. Significant differences are marked with different letters when a significant interaction was observed (p < 0.05). B × D was the interaction between the corresponding parameters. Nrf2, nuclear factor, erythroid 2-like 2; Hmox1, heme oxygenase 1.
Table 1.
Effect of curcumin on growth performance of intrauterine growth retardation weaned piglets (50 day).
Table 1.
Effect of curcumin on growth performance of intrauterine growth retardation weaned piglets (50 day).
Items | Experiment Groups | p-Value |
---|
NBW | NC | IUGR | IC | B | D | B × D |
---|
BWG (kg) | 6.02 ± 0.04 a | 5.95 ± 0.08 ab | 4.44 ± 0.04 c | 5.31 ± 0.05 b | <0.01 | <0.01 | <0.01 |
FI (kg) | 7.23 ± 0.14 a | 7.45 ± 0.10 a | 5.13 ± 0.10 c | 6.17 ± 0.17 b | <0.01 | 0.68 | <0.01 |
G:F (kg/kg) | 0.83 ± 0.02 | 0.80 ± 0.01 | 0.87 ± 0.01 | 0.86 ± 0.03 | 0.43 | 0.56 | 0.20 |
Table 2.
Effect of curcumin on the serum antioxidant enzymes activities of weaned piglets with intrauterine growth retardation (50 day).
Table 2.
Effect of curcumin on the serum antioxidant enzymes activities of weaned piglets with intrauterine growth retardation (50 day).
Items | Experiment Groups | p-Value |
---|
NBW | NC | IUGR | IC | B | D | B × D |
---|
TAOC (U/mL) | 1.94 ± 0.50 b | 2.08 ± 0.64 a | 1.03 ± 0.37 c | 1.89 ± 0.57 b | 0.01 | 0.01 | 0.06 |
CAT (U/mL) | 4.68 ± 1.15 b | 6.88 ± 1.08 a | 1.77 ± 0.43 c | 3.59 ± 1.27 b | <0.01 | <0.01 | 0.61 |
GSH-Px (U/mL) | 421.06 ± 63.75 a | 388.53 ± 38.06 ab | 355.29 ± 50.57 b | 376.87 ± 25.39 ab | 0.03 | 0.74 | 0.11 |
GR (U/L) | 23.98 ± 2.73 bc | 25.79 ± 4.34 a | 21.47 ± 1.38 c | 30.14 ± 1.24 a | 0.35 | <0.01 | <0.01 |
Table 3.
Effect of intrauterine growth retardation on the hepatic antioxidant enzyme activities of newborn piglets (0 day).
Table 3.
Effect of intrauterine growth retardation on the hepatic antioxidant enzyme activities of newborn piglets (0 day).
Items | NBW | IUGR | p-Value |
---|
TAOC (U/mg protein) | 0.65 ± 0.10 | 0.48 ± 0.05 | <0.01 |
CAT (U/mg protein) | 12.66 ± 1.44 | 12.81 ± 1.43 | 0.83 |
GSH (µmol/g protein) | 66.78 ± 17.84 | 80.78 ± 13.29 | 0.10 |
GSSG (µmol/g protein) | 21.06 ± 2.69 | 17.92 ± 4.16 | 0.10 |
GSSG:GSH | 0.22 ± 0.05 | 0.34 ± 0.13 | 0.04 |
GSH-Px (U/mg protein) | 26.03 ± 0.70 | 22.43 ± 1.19 | <0.01 |
GR (U/g protein) | 15.13 ± 2.79 | 11.67 ± 3.47 | 0.03 |
Table 4.
Effect of curcumin on the serum AST and ALT, and hepatic antioxidant enzymes activities of weaned piglets with intrauterine growth retardation (50 day).
Table 4.
Effect of curcumin on the serum AST and ALT, and hepatic antioxidant enzymes activities of weaned piglets with intrauterine growth retardation (50 day).
Items | Experiment Groups | p-Value |
---|
NBW | NC | IUGR | IC | B | D | B × D |
---|
Serum | | | | | | | |
AST (U/L) | 21.65 ± 0.90 c | 18.69 ± 1.07 d | 25.93 ± 0.84 a | 23.27 ± 0.89 b | 0.02 | 0.01 | 0.07 |
ALT (U/L) | 13.52 ± 1.53 c | 13.21 ± 1.43 c | 20.78 ± 1.67 a | 18.23 ± 1.97 b | <0.01 | 0.07 | 0.03 |
Liver | | | | | | | |
TAOC (U/mg protein) | 1.00 ± 0.11 ab | 1.00 ± 0.06 ab | 0.88 ± 0.14 b | 1.21 ± 0.22 a | 0.37 | <0.01 | <0.01 |
CAT (U/mg protein) | 7.92 ± 0.60 ab | 7.43 ± 0.55 b | 8.97 ± 0.79 a | 7.73 ± 0.63 b | 0.01 | <0.01 | 0.12 |
GSH-Px (U/mg protein) | 47.05 ± 6.73 b | 43.62 ± 7.36 b | 36.23 ± 2.04 c | 58.30 ± 5.17 a | 0.35 | <0.01 | <0.01 |
GR (U/g protein) | 15.17 ± 1.27 b | 19.86 ± 3.57 a | 16.11 ± 1.22 b | 18.94 ± 3.36 a | 0.99 | 0.32 | <0.01 |
Table 5.
Effect of intrauterine growth retardation on the hepatic nuclear factor, erythroid 2-like 2 (Nfe2l2), heme oxygenase-1 (Hmox1), Cat, and glutathione peroxidase 1 (Gpx1) gene expressions of newborn piglets (0 day).
Table 5.
Effect of intrauterine growth retardation on the hepatic nuclear factor, erythroid 2-like 2 (Nfe2l2), heme oxygenase-1 (Hmox1), Cat, and glutathione peroxidase 1 (Gpx1) gene expressions of newborn piglets (0 day).
Items | NBW | IUGR | p-Value |
---|
Nfe2l2 | 1.00 ± 0.01 | 0.36 ± 0.03 | <0.01 |
Hmox1 | 1.00 ± 0.03 | 0.76 ± 0.05 | <0.01 |
Cat | 1.00 ± 0.02 | 0.67 ± 0.02 | <0.01 |
Gpx1 | 1.00 ± 0.04 | 0.69 ± 0.06 | <0.01 |
Table 6.
Effect of curcumin on the hepatic nuclear factor, erythroid 2-like 2 (Nfe2l2), heme oxygenase-1 (Hmox1), Cat, and glutathione peroxidase 1 (Gpx1) gene expressions of weaned piglets with intrauterine growth retardation (50 day).
Table 6.
Effect of curcumin on the hepatic nuclear factor, erythroid 2-like 2 (Nfe2l2), heme oxygenase-1 (Hmox1), Cat, and glutathione peroxidase 1 (Gpx1) gene expressions of weaned piglets with intrauterine growth retardation (50 day).
Items | Experiment Groups | p-Value |
---|
NBW | NC | IUGR | IC | B | D | B × D |
---|
Nfe2l2 | 1.00 ± 0.07 b | 1.25 ± 0.32 b | 0.57 ± 0.16 c | 2.04 ± 0.05 a | 0.01 | <0.01 | <0.01 |
Hmox1 | 1.00 ± 0.26 a | 1.05 ± 0.09 a | 0.54 ± 0.10 b | 0.59 ± 0.13 b | <0.01 | 0.36 | 0.98 |
Cat | 1.00 ± 0.26 b | 1.24 ± 0.11 a | 0.55 ± 0.10 c | 0.52 ± 0.05 c | <0.01 | 0.06 | 0.02 |
Gpx1 | 1.00 ± 0.17 b | 1.15 ± 0.16 b | 0.60 ± 0.09 c | 1.76 ± 0.12 a | 0.05 | <0.01 | <0.01 |